Citrullination at the Inflammatory Skin Barrier
TLDR A potential treatment for atopic dermatitis could be to increase PADI1 expression to improve skin barrier function.
The study "Citrullination at the Inflammatory Skin Barrier" investigates the role of PADI1 in atopic dermatitis (AD). It reveals that PADI1 expression is reduced in AD-affected skin, leading to decreased citrullination of proteins crucial for skin barrier function. Baricitinib, a JAK1/2 inhibitor, can counteract this reduction, suggesting a therapeutic potential. The research indicates that restoring PADI1 expression might improve skin barrier function in AD, though the impact on enzyme activity is still uncertain. Future studies may look into drug combinations to boost PADI1 expression and activity, offering new treatment possibilities for inflammatory skin conditions.
